Skip to content
Open access

Canonical and isomiR products of miR-142 enhance dendritic cell reprogramming.

Aug 2026 · Cell Reports · Vol 45 8, pp. 117825 · 0 citations · 85 references
Medicine

TL;DR

These findings uncover miRNA isoform diversity as a programmable regulatory layer in immune cell specification and establish RNA-driven reprogramming as a non-viral strategy for cancer immunotherapy.

Abstract

MicroRNAs (miRNAs) regulate gene expression and generate isoforms (isomiRs) with distinct targeting properties, but their roles in cellular specification and reprogramming remain poorly understood. Here, we investigated miRNAs and isomiRs during direct reprogramming to conventional type 1 dendritic cells (cDC1s), identifying miR-124 and miR-142 as facilitators of the process. The canonical miR-124-3p strand induced a permissive chromatin landscape enriched for cooperative transcription factor motifs, thereby transiently increasing reprogramming efficiency. In contrast, miR-142 enhanced lineage fidelity by repressing fibroblast identity and activating cDC1-specific programs through cooperating isomiRs that drove XCR1 expression and increased type 3 interferon production. In addition, miR-142 mimics enhanced cancer cell reprogramming and anti-tumor immunity in vivo. Finally, we developed RNA-based cDC1 reprogramming using transcription factor mRNAs combined with miRNA mimics. Together, these findings uncover miRNA isoform diversity as a programmable regulatory layer in immune cell specification and establish RNA-driven reprogramming as a non-viral strategy for cancer immunotherapy.

Read PDF

Similar papers

Open access Sep 2026

miRNA Isoform Spectrum Expansion by Overexpression May Affect Target Gene Silencing.

MicroRNAs (miRNAs) regulate gene expression primarily through translational inhibition and mRNA degradation. Their functional complexity is increased by the presence of various mature isoforms (isomiRs). These isomiRs add diversity to miRNA targeting and regulation, yet their impact on cellular systems remains insuffic...

Fabian Kern, Martin Hart, Lena Krammes et al. · 0 citations
Open access Aug 2026

Dual-mode SOX2 regulation by miR-150 via mRNA suppression and autophagy controls stem cell fate

A role for miR-150 deficiency in biasing ectoderm–mesoderm lineage specification in hPSCs is defined and SOX2 is identified as a key downstream node regulated primarily through altered mRNA stability, with additional involvement of an autophagy-associated pathway.

Xing Zhen, Hyebin Koh, Dong-Seok Lee et al. · 0 citations
Open access Aug 2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities

Investigation of whether miR-155-5p and miR-3535 represent regulators capable of driving coordinated functional reprogramming of both, tumor cells and macrophages found they modulate tumor-intrinsic immune checkpoint expression and functional macrophage polarization in a coordinated way.

Theresa Kordaß, Ann-Katrin Schlosser, Marijan Czygan et al. · 0 citations
Open access Oct 2026

SEC Mediates m6A Deposition and Transcription Pause Release to Drive Cell Identity Transition

ABSTRACT Background: Induced pluripotent stem cell (iPSC) reprogramming and embryonic stem cell (ESC) differentiation represent opposite models of cell identity transition, yet their regulatory mechanisms remain incompletely understood. Here, we identify the Super Elongation Complex (SEC), the most pivotal regulators o...

Zhi-Jing Zhang, Jing-Yi Xu, Yong-Hong Wu et al. · 0 citations
Open access Sep 2026

The crosstalk between alternative splicing and histone ubiquitination modulates fast chemical reprogramming to pluripotency.

Cellular reprogramming has revolutionized regenerative medicine. Recently, we develop a fast chemical reprogramming (FCR) system; however, the underlying molecular mechanisms remain largely unknown. Here, we investigated the dynamics of RNA-binding protein (RBP) expression and alternative splicing (AS) events in the FC...

Qiang Deng, Xi Chen, Yu-Han Li et al. · 0 citations
Review Open access Oct 2026

Aberrant Transcription-Factor Expression and Regulatory microRNAs in Metastatic Breast Cancer

Metastatic breast cancer is driven by reversible cell-state programs shaped by transcription factors (TFs) and microRNAs (miRNAs). Dysregulated TFs integrate oncogenic signaling, hypoxia, inflammation, lineage identity, mechanical cues, and chromatin state, whereas miRNAs buffer or reinforce these programs through post...

E. H. Althubaiti · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.